Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Deals

Embrace the competition from China, says Maraganore

U.S. biotechs need to rise to the challenge and learn from their competitors

By C. Simone Fishburn, Editor in Chief
February 14, 2025 9:07 PM UTC

The rising competition from China is to be welcomed not feared, says John Maraganore, who argues the innovation will push biotechs globally to greater heights and provide a net positive for patients and the biopharma ecosystem.

In a fireside chat with BioCentury at the BIO CEO & Investor Forum in New York on Feb. 11, Maraganore, the former and longtime CEO of  Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) who is now chairman of  City Therapeutics Inc., took a strong stance to encourage openness to this new source of competition...

Get Unlimited Access
To view this item, login or register for a free account.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Alnylam Pharmaceuticals Inc.

City Therapeutics Inc.